Medical Solution Manufacturing and Formulation

The contract involves the manufacture and sterile formulation of a medical solution composed of Dextrose 5% in 0.2% Sodium Chloride Injection, classified as a Type I (Code M) product. This solution will have a strict 24-month shelf life, which is non-extendable, and all manufacturing processes must adhere to FDA and current Good Manufacturing Practice (cGMP) standards to ensure quality and compliance. The contract is a subcontract issued by the Department of Defense under the Medical Supply Chain Pharmacological FSA and is designated with NAICS code 325412. The performance location for this contract is Fort Irwin, with a deadline for responses set shortly after posting, indicating a prompt procurement timeframe. The contract obligates the subcontractor to produce a sterile, standardized medical injection suitable for military or related medical supply needs, emphasizing compliance, high quality, and regulatory requirements. No specific set-aside types are mentioned, and the solicitation does not provide contact details beyond the government website for reference.